Skip to main content
. Author manuscript; available in PMC: 2017 Jan 1.
Published in final edited form as: Ann Vasc Surg. 2015 Jul 14;30:72–81.e2. doi: 10.1016/j.avsg.2015.04.092

Figure 2.

Figure 2

Risk-adjusted average cost for patients stratified by occurrence of kidney disease among patients who (A) died within 90 days of admission (B) did not die within 90 days of admission.

*denotes significance difference between no kidney disease and AKI groups.

#denotes significance difference between no kidney disease and CKD groups.